Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 7/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.34 |
| ▸ | FEN1 | P39748 | 2/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | NSD2 | O96028 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20617036 | 0.96 | AR (0.37) | RXRARXRGARALOX5APFEN1 | |
| SCHEMBL19912448 | 0.95 | AR (0.37) | ARALOX5APFEN1XDHPGR | |
| SCHEMBL22822541 | 0.93 | ALOX5AP (0.36) | RXRARXRGARALOX5APFEN1 | |
| SCHEMBL22822325 | 0.92 | RXRA (0.35) | RXRARXRGARALOX5APFEN1 | |
| SCHEMBL19917978 | 0.91 | AR (0.39) | ARALOX5APFEN1KIF11XDH | |
| SCHEMBL22760625 | 0.91 | PTGDR2 (0.38) | ARALOX5APFEN1XDHPGR | |
| SCHEMBL21258698 | 0.91 | AR (0.40) | ARALOX5APFEN1KIF11XDH | |
| SCHEMBL22822582 | 0.91 | AR (0.37) | RXRARXRGARALOX5APFEN1 | |
| SCHEMBL20617035 | 0.91 | AR (0.37) | RXRARXRGARALOX5APFEN1 | |
| SCHEMBL20111879 | 0.90 | RXRA (0.34) | RXRARXRGARALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021473-B2 | Organic molecules for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| US-20200399256-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021473-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | RXRA 3552/4885RXRG 3138/4885AR 4374/4885 |
| US-20200399256-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | RXRA 3876/4885RXRG 3543/4885AR 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.